tiprankstipranks
Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7

Halozyme (RV7) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Halozyme
€56.30
$6.95B
17.74
46.59%
5 Buy
4 Hold
0 Sell
Moderate Buy
Amgen
$312.50
$171.31B
43.30
16.68%
10 Buy
6 Hold
1 Sell
Moderate Buy
Biogen
$140.19
$21.03B
12.85
-38.12%
12 Buy
12 Hold
0 Sell
Moderate Buy
Gilead Sciences
$113.99
$142.50B
306.43
58.03%
17 Buy
5 Hold
0 Sell
Strong Buy
Regeneron
$689.50
$78.51B
18.73
-28.49%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$495.42
$125.40B
20.12%
15 Buy
11 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:RV7
Halozyme
56.26
18.04
47.20%
AMGN
Amgen
312.50
44.68
16.68%
BIIB
Biogen
140.19
-86.37
-38.12%
GILD
Gilead Sciences
113.99
41.03
56.24%
REGN
Regeneron
689.50
-274.73
-28.49%
VRTX
Vertex Pharmaceuticals
495.42
82.22
19.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis